Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
First-time investors can benefit greatly from expert advice. Learn key strategies to navigate the investment landscape effectively.
28,248 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Gas prices are seeping into household budgets and market bets, with analysts warning that the pump’s visibility could...
A missile strike on Qatar’s LNG facilities pushes oil and gas markets higher. Traders point to wall street buying the...
A major crypto development is sending ripples through the market as Ethereum reacts to optimistic signals from Iran a...
The nuclear energy story 2026 is taking shape as decarbonization and power-hungry data demand push expansion. This gu...
Invesco's PZA continues its long-running monthly payouts, signaling that credit quality and reinvestment strength kee...
Berkshire Hathaway disclosed a $2.65 billion stake in Delta Air Lines, marking a sharp shift from Buffett-era airline...
A fresh analysis tests whether a $10,000 crypto investment can turn into $1 million by 2030, focusing on BTC, ETH, XR...
AI-driven demand for high-bandwidth memory is squeezing the global supply, raising costs for devices and testing Appl...
As oil markets shift, offshore drilling and onshore completion services offer different paths to profits. This compar...
Caterpillar—a 100-year-old icon in heavy equipment—is redefining its path by embracing AI-enabled infrastructure, dat...
The Intelligent Alpha CEO unveils the Mag-7, spotlighting Google and Apple as the central players in the personal AI ...